SHARE THIS VIDEO —
Pancreatic cancer vaccine shows promise in early trial
NBC News Clone summarizes the latest on: Mmvo244772933953 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.
A one-size-fits-all vaccine has shown promising results in keeping hard-to-treat pancreatic cancers from coming back. The five-year survival rate for this type of cancer is about 13%, and up to 80% of pancreatic cancers may come back.
NBC News Clone will keep curating essential reads for you — simplified and optimized.
